| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-02 | FY 2024
FILED 2025-01-03 | FY 2023
FILED 2023-12-29 |
|---|---|---|---|
| Revenue (Total Sales) | $7.79B | $7.71B | $6.96B |
| YoY Revenue Growth % | +1.0% | +10.8% | — |
| Gross Profit | $1.15B | $1.10B | — |
| Gross Margin % | 14.8% | 14.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $778.0M | $659.0M | $449.0M |
| Operating Margin % | 10.0% | 8.5% | 6.5% |
| Net Income (GAAP) | $415.0M | $375.0M | -$265.0M |
| EBITDA (Normalized) | $811.6M | $700.6M | $699.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | — | $462.0M | $331.0M |
| Capital Expenditures (CapEx) | $42.0M | $52.0M | $313.0M |
| Free Cash Flow (FCF) | — | $410.0M | $18.0M |
| FCF Margin % | — | 5.3% | 0.3% |
| Return on Invested Capital (ROIC %) | 17.3% | 14.3% | 7.0% |
| Cash & Short-Term Equivalents | $500.0M | $342.0M | — |
| Total Debt (Short + Long Term) | $2.55B | $2.53B | $1.95B |
| Total Stockholders' Equity | $1.50B | $1.45B | $4.01B |